Dexcom CGM in Long-term Care - Trial NCT04818242
Access comprehensive clinical trial information for NCT04818242 through Pure Global AI's free database. This phase not specified trial is sponsored by Emory University and is currently Recruiting. The study focuses on Diabetes,Diabetes Mellitus, Type 2. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Emory University
Timeline & Enrollment
N/A
Apr 19, 2021
Dec 01, 2023
Primary Outcome
Number of events of Hypoglycemia 70 mg/dl,Number of events of clinically significant hypoglycemia 54 mg/dl,Time in range (TIR) between 80-180 mg/dl
Summary
Diabetes is prevalent in adults admitted to subacute rehab (SAR) and long-term care (LTC)
 skilled nursing care facilities. Management of diabetes in these facilities is challenging
 due to number of older adults with higher prevalence of other diseases, functional
 disability, and altered nutritional intake, which increase the risk of hypoglycemia (low
 blood sugars). The investigators propose to conduct this randomized controlled trial to
 determine whether the use of Dexcom CGM with Glucose Telemetry System (CGM-GTS) with
 hypoglycemia alarm compared to standard of care using capillary POC testing, will facilitate
 diabetes treatment and reduce the risk of hypoglycemia in patients with T2D in LTC
 facilities. Participants in the standard of care group will also wear a CGM (blinded one).
 The results of this study have great potential to impact and facilitate care and to change
 current clinical guidelines in the management of older adults with diabetes in SAR and LTC
 facilities.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04818242
Device Trial